Literature DB >> 9737871

Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.

K M Arndt1, K M Müller, A Plückthun.   

Abstract

Antibody single-chain Fv (scFv) fragments are able to form dimers under certain conditions, and the extent of dimerization appears to depend on linker length, antibody sequence, and external factors. We analyzed the factors influencing dimer-monomer equilibrium as well as the rate of interconversion, using the scFv McPC603 as a model system. In this molecule, the stability of the VH-VL interaction can be conveniently varied by adjusting the ionic strength (because of its influence on the hydrophobic effect), by pH (presumably because of the presence of titratable groups in the interface), and by the presence or absence of the antigen phosphorylcholine, which can be rapidly removed due to its very fast off-rate. It was found that the monomer is the thermodynamically stable form with linkers of 15 and 25 amino acids length under all conditions tested (35 microM or less). The dimer is initially formed in periplasmic expression, presumably by domain swapping, and can be trapped by all factors which stabilize the VH-VL interface, such as the presence of the antigen, high ionic strength, and pH below 7.5. Under all other conditions, it converts to the monomer. Predominantly monomer is obtained during in vitro folding. Monomer is stabilized against dimerization at very high concentrations by the same factors which stabilize the VH-VL interaction. These results should be helpful in producing molecules with defined oligomerization states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737871     DOI: 10.1021/bi9810407

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

Review 1.  The Landscape of Intertwined Associations in Homooligomeric Proteins.

Authors:  Shoshana J Wodak; Anatoly Malevanets; Stephen S MacKinnon
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

2.  Characterization of the 4D5Flu single-chain antibody with a stimulus-responsive elastin-like peptide linker: a potential reporter of peptide linker conformation.

Authors:  Mark A Blenner; Scott Banta
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

3.  Single-chain Fv-based anti-HIV proteins: potential and limitations.

Authors:  Anthony P West; Rachel P Galimidi; Priyanthi N P Gnanapragasam; Pamela J Bjorkman
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strains.

Authors:  Jürgen Schanzer; Andreas Jekle; Junichi Nezu; Adriane Lochner; Rebecca Croasdale; Marianna Dioszegi; Jun Zhang; Eike Hoffmann; Wilma Dormeyer; Jan Stracke; Wolfgang Schäfer; Changhua Ji; Gabrielle Heilek; Nick Cammack; Michael Brandt; Pablo Umana; Ulrich Brinkmann
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

5.  Optimization of the crystallizability of a single-chain antibody fragment.

Authors:  Jana Škerlová; Vlastimil Král; Milan Fábry; Juraj Sedláček; Václav Veverka; Pavlína Rezáčová
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

6.  Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.

Authors:  Romany Abskharon; Paul M Seidler; Michael R Sawaya; Duilio Cascio; Tianxiao P Yang; Stephan Philipp; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; Philip L Felgner; Rie Nakajima; Charles G Glabe; David S Eisenberg
Journal:  J Biol Chem       Date:  2020-06-03       Impact factor: 5.157

7.  A fully human scFv phage display library for rapid antibody fragment reformatting.

Authors:  Keyu Li; Kirstin A Zettlitz; Julia Lipianskaya; Yu Zhou; James D Marks; Parag Mallick; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2015-05-19       Impact factor: 1.650

8.  Module based antibody engineering: a novel synthetic REDantibody.

Authors:  Anatoliy Markiv; Bernard Anani; Ravi V Durvasula; Angray S Kang
Journal:  J Immunol Methods       Date:  2010-11-03       Impact factor: 2.303

9.  Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.

Authors:  Jeffrey V Leyton; Tove Olafsen; Mark A Sherman; Karl B Bauer; Patrick Aghajanian; Robert E Reiter; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2008-10-28       Impact factor: 1.650

10.  ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).

Authors:  Tove Olafsen; Shannon J Sirk; David J Betting; Vania E Kenanova; Karl B Bauer; Waldemar Ladno; Andrew A Raubitschek; John M Timmerman; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2010-01-06       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.